Dumaldal, Baby Girl .

HRN: 23-66-14  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2023
AMPICILLIN 250MG (VIAL)
12/20/2023
12/26/2023
IV
70mg
Q12
Prematurity
Waiting Final Action 
12/20/2023
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/20/2023
12/26/2023
IV
21mg
Q24
Prematurity
Waiting Final Action 
12/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/24/2023
12/31/2023
IV INFUSION
21mg
Once
NEC
Waiting Final Action 
12/24/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/24/2023
12/31/2023
IV INFUSION
11mg
Q24
NEC
Waiting Final Action 
12/24/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
12/24/2023
12/31/2023
IV INFUSIONS
17mg
Q12
NEC
12/30/2023
CIPROFLOXACIN 500MG (TAB)
12/30/2023
01/06/2024
PER OGT
25mg Pptab
BID
Sepsis
Waiting Final Action 
12/31/2023
FLUCONAZOLE 2MG/ML, 100ML (VIAL)
12/31/2023
01/07/2024
IVT
30 Mg, 15 Mg
Od
Fungal Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: